Cystic fibrosis is a serious inherited disease which mainly affects the lungs and pancreas, but can involve other organs. Symptoms usually begin in early childhood and include persistent cough, wheeze, repeated chest infections, malabsorption of food and general ill health. Treatments include antibiotics, physiotherapy, mucus thinning medicines, pancreatic enzyme replacements and other therapies.
What is cystic fibrosis?
Cystic fibrosis is a condition which mainly affects the lungs and pancreas, but can affect other parts of the body, including the liver, nose and sinuses, reproductive organs, and sweat glands. Normally, cells in these parts of the body make mucus and other watery juices and secretions.
In people with cystic fibrosis, these cells do not function correctly and make mucus and secretions which are thicker than normal. This can cause various symptoms and problems (which are described below).
What causes cystic fibrosis and how common is it?
Cystic fibrosis is a genetic disorder. If you have cystic fibrosis, one of your genes does not work properly. This is known as a CFTR gene which is on chromosome 7. There are different mutations that can occur in this gene and this means that there are different severities of cystic fibrosis that occur.
This gene helps to control the way the cells handle sodium and chloride ions (salt). The mutation in the gene results in the cells being unable to handle sodium and chloride properly.
As a result, cells in affected organs have a fault in the way sodium and chloride travel in and out of the cells. Basically, too much sodium travels into the cells. Water follows the sodium, which leaves too little water outside the cells. This causes the mucus or watery secretions outside the cells to be too thick (for example, in the airways of the lungs).
About 1 in 2,500 babies in the UK are born with cystic fibrosis. Over 9,000 people currently have cystic fibrosis in the UK. Cystic fibrosis is an autosomal recessive disorder. This means that in order to develop cystic fibrosis you need to inherit two cystic fibrosis genes, one from your mother and one from your father. If you inherit only one cystic fibrosis gene, you are called a carrier.
About 1 in 25 people in the UK of Caucasian descent (white European) are carriers of the cystic fibrosis gene. It is much less common in Afro-Caribbean and Asian people. Carriers do not have the disease, as they have one normal gene which can control the salt transport in their cells. But carriers can pass the cystic fibrosis gene on to their children.
When two people who carry the cystic fibrosis gene have a child, there is a:
- 1 in 4 chance that the child will have cystic fibrosis (by inheriting the cystic fibrosis gene from both parents).
- 2 in 4 chance that the child will not have cystic fibrosis, but will be a carrier (by inheriting a cystic fibrosis gene from one parent but the normal gene form the other parent).
- 1 in 4 chance that the child will not have cystic fibrosis, and will not be a carrier (by inheriting the normal gene from both parents).
What are the symptoms of cystic fibrosis?
Cystic fibrosis symptoms usually first develop within the first year of life, but may not appear until later childhood. The severity of symptoms can vary.
The cells that line the airways of the lungs make sputum (mucus) that is thicker than normal, and which is not cleared from the lungs easily. This can trap bacteria in the small airways and lead to infection and inflammation. So, symptoms which typically develop include:
- Persistent cough which typically produces a lot of sputum.
- Shortness of breath and breathing difficulties.
- Recurring chest infections. These can be severe, such as pneumonia. Repeated infections and inflammation can damage the lungs and lead to poor lung function.
The pancreas normally makes digestive juices which contain chemicals (enzymes). The digestive juices normally flow out from the pancreatic duct into the duodenum and digest food.
In people with cystic fibrosis, thickened secretions block the normal flow of the digestive juices from the pancreas. This can result in food not being digested or absorbed properly - in particular, fatty foods and fat-soluble vitamins (vitamins A, D, E and K).
This can cause:
- Malnutrition leading to poor growth and poor weight gain (even if you have a good appetite and eat a lot, as the problem is with digesting and absorbing the food).
- Large, smelly, greasy, fatty faeces (stools or motions) occur in about a third of cases.
- Bloated abdomen.
In about 3 in 10 cases the pancreas functions well and there are no or minimal gut symptoms, and mainly just lung symptoms.
Symptoms sometimes occur at birth
About 1 in 10 children with cystic fibrosis are diagnosed shortly after birth. This is due to a condition called meconium ileus where in some cases the gut becomes blocked with meconium - a thick, dark, sticky substance which is made by the baby's gut before being born. Urgent surgery may be needed to relieve the blockage.
Other symptoms and complications
Other organs may be affected which may cause various other problems in some cases. Also, the pancreas and airways may become severely affected. Therefore, other problems which may also occur in some cases include:
- Repeated sinus infections.
- Polyps forming in the nose.
- Infertility (especially in males, as the tubes which carry the sperm can become blocked).
- Damage to the liver, which may lead to cirrhosis, occurs in about 1 in 12 cases (if the small ducts in the liver become blocked or damaged).
- Diabetes. (Special cells in the pancreas make insulin. If the pancreas becomes severely damaged over time then insulin levels go down and diabetes may develop.) This is rare in children but is more common in adults who have had cystic fibrosis.
- Pancreatitis (inflammation of the pancreas).
- Rectal prolapse.
- Osteoporosis (thinning of the bones) may develop due to poor absorption of certain foods and, in particular, vitamin D which is needed to maintain healthy bones.
- The sweat tastes very salty.
Some cases of cystic fibrosis are diagnosed in adults who have relatively mild symptoms. This may be due to some mutations of the cystic fibrosis gene not being as faulty as others. The handling of sodium and chloride may only be mildly affected in these cases.
How is cystic fibrosis diagnosed?
A doctor may arrange a sweat test if he or she suspects cystic fibrosis from the symptoms. This test measures the amount of salt (sodium and chloride) in skin sweat. People with cystic fibrosis have an abnormally high salt level in sweat.
A genetic test can confirm the diagnosis. Some cells are either scraped from the inside of the cheek or taken from a blood test. These can be tested to detect the cystic fibrosis gene.
All newborn babies in the UK are now screened for cystic fibrosis. A small heel prick blood test is taken about the sixth day after birth. This can detect a chemical called immunoreactive trypsinogen which is high in babies with cystic fibrosis. If it is high then a sweat test and genetic test can be done to confirm the diagnosis. Screening is considered important because the earlier the diagnosis is made, the sooner treatment can begin which improves the outlook (prognosis).
Cystic fibrosis treatment
There are many aspects to the treatment of people with cystic fibrosis. Treatment involves the input, advice, and expertise of various professionals, such as child health doctors, specialist nurses, physiotherapists, dieticians, counsellors and psychologists as well as your primary healthcare team.
It is usual to have regular checks and tests to monitor the condition and to keep a check on children's growth, development and well-being.
The following list is a brief overview of the commonly used treatments, but is not a full or exhaustive account of all the treatments used. An individual treatment plan is needed for each case to take into account individual circumstances.
TREATMENTS FOR LUNG PROBLEMS
Physiotherapy and exercise
Regular chest physiotherapy is very important. This helps to clear the airways of the thick mucus. A physiotherapist usually shows parents how to do this for their children. It involves a special way to firmly pat the chest whilst the child lies head-down to encourage mucus and sputum to be coughed out. Twice-daily chest physiotherapy is common practice. This may need to be increased during times of chest infections.
There is a wide variety of airway clearance techniques available and your physiotherapist will be able to advise you on the most suitable technique or techniques for you. These are likely to change though as you become older or as your disease changes with time.
It is also important to encourage children to exercise and to be as active and fit as possible. So, sports and games such as running, swimming, football and tennis are encouraged.
Antibiotics and antifungals
Courses of antibiotics are a mainstay of treatment. Many children with cystic fibrosis take regular long-term antibiotics. The dose is increased and/or other types of antibiotics are given when a chest infection develops. Various bacteria can cause infections and the antibiotics chosen depend on which bacteria are found in samples of sputum. Antibiotics given intravenously (into a vein) are often required for severe infections that are not controlled with antibiotic tablets. They can also be given by a nebuliser.
A bacterium called Pseudomonas aeruginosa commonly persists in the thick mucus in the airways. To keep this from flaring up into repeated infections, an antibiotic given by nebuliser (inhaled antibiotic) or inhaler is a common treatment.
Sometimes the lungs become infected with a fungus and antifungal medication is required.
Inhalers to open up the airways as much as possible may be used - for example, salbutamol. This is similar to the treatment used for asthma.
This is a medicine given by nebuliser in some cases. It helps to break down and to thin the thick mucus, making it easier to cough up and clear the mucus from the airways. It may reduce the number of lung infections and help to improve lung function.
People with advanced lung disease may benefit from oxygen, particularly overnight.
Other medication to improve lung function - for example, ibuprofen and azithromycin - may also be recommended in some cases.
TREATMENTS FOR PANCREATIC PROBLEMS
The enzymes needed to digest food are greatly reduced in most people with cystic fibrosis. Therefore children with cystic fibrosis need a high fat and carbohydrate diet. A dietician will usually give detailed advice. High-energy drink supplements may also be needed. In addition, vitamin supplements are needed, as many vitamins in food are not absorbed very well. Being well nourished will also help you to fight any chest infections.
In most cases, enzyme supplements are needed to help to digest food. (These replace the enzymes which normally come from the pancreas.) You need to take these supplements every time you eat food. This can mean taking many doses each day.
A range of other problems which are related to cystic fibrosis may develop in some cases and require treatment. For example:
- Salt depletion may occur in hot weather and may require salt supplements.
- Liver problems develop in some cases and may require specialist liver treatments.
- If diabetes develops, it usually requires insulin or tablet treatment.
- Nasal polyps sometimes develop and can be treated with steroid nasal drops and sprays.
- Acid reflux from the stomach into the gullet (oesophagus) is common and can be treated with medicines which reduce the acid content of the stomach juices.
- Constipation is quite common and may require regular laxatives.
- All people with cystic fibrosis should be up to date with routine immunisations, and also have an annual flu jab to prevent influenza and a pneumococcal vaccine to help prevent pneumonia caused by this bacteria.
- Some children are tested for their immunity against varicella (chickenpox). If you do not have immunity to it then you may be offered the vaccine against chickenpox.
- Lung or heart/lung transplantation may be offered in some cases as the lung disease becomes more severe.
Newer treatments are being researched and developed and, if found successful, may become more widely used in the future. For example:
- Gene therapy. This involves using an inhaled spray to deliver normal copies of the cystic fibrosis gene to the lungs.
- Medicines are being tested which may correct the abnormal salt and water regulation of cells that leads to thickened mucus and secretions being made in the lungs and other organs.
- New methods to improve the action of the current treatments are being developed.
What is the outlook (prognosis)?
Cystic fibrosis is a lifelong condition. With improved treatment there has been a dramatic increase in the survival of people with cystic fibrosis over a period of 20 years or so.
In the 1960s and before, most babies born with cystic fibrosis only survived for a few months or years. Today, many people with cystic fibrosis are living into their late 30s and beyond. With optimal care and treatment, it is estimated that about 8 in 10 of today's children with cystic fibrosis should live into their mid 40s or 50s. With treatment, most people with cystic fibrosis can live reasonably normal and productive lives.
However, there will be times when symptoms are more severe - mainly when a chest infection develops. Even with treatment, the main risk is recurring chest infections, and pneumonia. This can have a repeated damaging effect on lung function which can get worse over time. Death in childhood or early adulthood is still not uncommon. Most people with cystic fibrosis die of lung complications, mainly respiratory, and heart failure.
People with a family history of cystic fibrosis may wish to have genetic counselling and testing to find out their risk of passing the condition on to their children. A simple test can be done to look at the genes from cells from the inside of the cheek or from blood. The test can detect the cystic fibrosis gene which can show if you are a carrier of the abnormal gene.
Further help and information
Cystic Fibrosis Trust
11 London Road, Bromley, Kent, BR1 1BY
Tel (helpline): 0845 859 1000 Web: www.cftrust.org.uk
Provides information and support for people with cystic fibrosis and for their carers.
Cystic Fibrosis Screening Programme
Information about the national screening programme for cystic fibrosis in the newborn.
Further reading & references
- Standards of medical care for people with cystic fibrosis - various guidelines and consensus documents, Cystic Fibrosis Trust (various dates)
- Sharma GD, Cystic Fibrosis, Medscape, Dec 2011
- Davies JC, Alton EW, Bush A; Cystic fibrosis. BMJ. 2007 Dec 15;335(7632):1255-9.
- Wicks E; Cystic fibrosis. BMJ. 2007 Jun 16;334(7606):1270-1.
- Jones AP, Wallis C; Dornase alfa for cystic fibrosis. Cochrane Database Syst Rev. 2010 Mar 17;(3):CD001127.
- Southern KW, Barker PM, Solis-Moya A, et al; Macrolide antibiotics for cystic fibrosis. Cochrane Database Syst Rev. 2011 Dec 7;12:CD002203.
- Ryan G, Singh M, Dwan K; Inhaled antibiotics for long-term therapy in cystic fibrosis. Cochrane Database Syst Rev. 2011 Mar 16;(3):CD001021.
- Moran A, Dunitz J, Nathan B, et al; Cystic fibrosis-related diabetes: current trends in prevalence, incidence, and Diabetes Care. 2009 Sep;32(9):1626-31. Epub 2009 Jun 19.
- O'Sullivan BP, Freedman SD; Cystic fibrosis. Lancet. 2009 May 30;373(9678):1891-904. Epub 2009 May 4.
Disclaimer: This article is for information only and should not be used for the diagnosis or treatment of medical conditions. EMIS has used all reasonable care in compiling the information but make no warranty as to its accuracy. Consult a doctor or other health care professional for diagnosis and treatment of medical conditions. For details see our conditions.
|Original Author: Dr Tim Kenny||Current Version: Dr Louise Newson||Peer Reviewer: Dr Helen Huins|
|Last Checked: 14/06/2012||Document ID: 4837 Version: 41||© EMIS|
The authors and editors of this article create up to date content reflecting reliable research evidence, guidance and best clinical practice. Learn more